MRP Capital Investments LLC Has $1.68 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

MRP Capital Investments LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,305 shares of the healthcare conglomerate’s stock after selling 460 shares during the quarter. UnitedHealth Group makes up 1.6% of MRP Capital Investments LLC’s holdings, making the stock its 18th biggest holding. MRP Capital Investments LLC’s holdings in UnitedHealth Group were worth $1,683,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Macroview Investment Management LLC grew its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $31,000. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 2nd quarter valued at approximately $31,000. Finally, Signature Resources Capital Management LLC lifted its position in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.4 %

NYSE:UNH opened at $580.32 on Thursday. The firm has a market cap of $535.88 billion, a price-to-earnings ratio of 35.47, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The firm has a 50-day moving average price of $574.38 and a two-hundred day moving average price of $519.42. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.14 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insiders Place Their Bets

In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday. Royal Bank of Canada raised their target price on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Monday. UBS Group boosted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Finally, TD Cowen increased their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.